Precigen, Inc. (PGEN) stock
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.21+0.05 (+1.20%)
Close on Nov 20, 2026Market cap $1.51BP/E –Yield –
Precigen gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Precigen's gross profit for the twelve months ending Jun 30, 2018 was $168.17M, up 0.3% year over year. For fiscal 2017 it was $186.20M, up 21.5% from the year before. The highest annual figure on record is $186.20M in fiscal 2017.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $186.20M | +21.5% |
| FY2016 | Dec 31, 2016 | $153.22M | +15.3% |
| FY2015 | Dec 31, 2015 | $132.86M | +118.2% |
| FY2014 | Dec 31, 2014 | $60.90M | +156.5% |
| FY2013 | Dec 31, 2013 | $23.74M | +72.3% |
| FY2012 | Dec 31, 2012 | $13.77M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | $32.13M | -29.5% |
| Q1 FY2018 | Mar 31, 2018 | $28.63M | -35.7% |
| Q4 FY2017 | Dec 31, 2017 | $69.39M | +83.7% |
| Q3 FY2017 | Sep 30, 2017 | $38.02M | -4.6% |
| Q2 FY2017 | Jun 30, 2017 | $45.57M | – |
| Q1 FY2017 | Mar 31, 2017 | $44.50M | – |
| Q4 FY2016 | Dec 31, 2016 | $37.76M | – |
| Q3 FY2016 | Sep 30, 2016 | $39.83M | – |
See a number that looks wrong?